Based on the most recent projections from Fact.MR, a competitive intelligence and market research firm, the global hip tendinitis market is expected to reach US$ 268.7 million in 2023 and grow at a compound annual growth rate (CAGR) of 5% until 2033.

The thick cords that connect muscle to the hip bone are called tendons, and hip tendonitis is an inflammation and degradation of these cords that is frequently brought on by overtraining. Another way that hip tendonitis arises is when an activity that a person is not used to undertaking puts the tendon under excessive strain. The tendons heal slowly because there is insufficient blood flow to them.

Get a Free Sample Copy of Hip Tendinitis Market Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=8471

Individuals who participate in physical activities like cycling, high-kicking, or jogging are at a higher risk of developing hip tendonitis. In addition, high-risk exercises like weightlifting and squat-based sports can cause hip tendinitis. Rapid increases in training volume and intensity are linked to an increased risk of hip tendinitis.

The global market for hip tendinitis is growing healthily as a result of rising hip tendonitis instances, an aging population, and an increase in the prevalence of diabetes. Furthermore, it is anticipated that the growing healthcare industry, the prevalence of sedentary lifestyles, and increased public knowledge of tendinitis will all contribute to an increase in the need for hip tendinitis remedies.

Key Takeaways from Market Study

By 2033, sales of products for hip tendinitis are projected to reach US$ 437.8 million.
Product sales growth is anticipated to be boosted by an increase in sports injury cases in the US.
Hip tendinitis is becoming more common in Germany due to the rising frequency of diabetes.
In Japan, the need for hip tendinitis treatment is being driven by the country's rapidly aging population, which is more likely to sustain orthopedic ailments.
Notable Market Developments

CoNextions Inc., a tendon restoration firm, said in May 2022 that the first patient had surgery using the CoNextions TR Tendon restoration System to treat a zone 2 flexor tendon in the little finger, just 19 days after the FDA granted 510(k) clearance for the product's sale.
A phase 3 clinical trial is being conducted on MiMedx's micronized dHACM Injection, which is intended to treat individuals with Achilles tendinitis.
Share Your Requirements & Get Customised Reports
https://www.factmr.com/connectus/sample?flag=RC&rep_id=8471

Competitive Landscape

Throughout the projected period, there will be a rise in the need for tendonitis treatment alternatives due to the increasing occurrence of tendon-related injuries among athletes and sports players in the general population.

In response to the increasing demand, major companies in the hip tendinitis market are undertaking multiple initiatives to expand their firm base and creating efficient plans for product development, according to Fact.MR, a source of competitive intelligence and market research. The industry's rise can be attributed, in part, to the balanced presence of both well-known worldwide corporations and regional producers.

Due to its ability to alleviate tendinitis symptoms and indicators, Naproxen Oral Suspension was added to Camber Pharmaceuticals' product line in November 2022.
Hip Tendinitis Products Companies

Almatica Pharma, Inc
AstraZeneca
Bayer AG
Boehringer Ingelheim Pharmaceuticals, Inc
Merck & Co., Inc
Pfizer
Abbott
GlaxoSmithKline plc
Teva Pharmaceuticals
Lupin Pharmaceuticals, Inc.
Geri-Care Pharmaceuticals.
Perrigo Company
Key Segments of Hip Tendinitis Industry Research

By Injury Type :
Internal Snapping Hip
External Snapping Hip
Intra-articular Snapping Hip
By Treatment :
Diagnosis
Physical Examination
Imaging Studies
Therapy
Pharmacological
Non-pharmacological
Shock Wave or Surgery
Medical Equipment
By End User :
Hospitals & Clinics
Medical Research Centers
Academic Institutes
By Region :
North America
Latin America
Europe
East Asia
South Asia & Oceania
MEA
More Valuable Insights on Offer

Fact.MR, in its new offering, presents an unbiased analysis of the global hip tendinitis market, presenting historical demand data (2018 to 2022) and forecast statistics for the period (2023 to 2033).

The study divulges essential insights on the market based on injury type (internal snapping hip, external snapping hip, intra-articular snapping hip), treatment (diagnosis, therapy), and end user (hospitals & clinics, medical research centers, academic institutes), across five major regions of the world (North America, Europe, Asia Pacific, Latin America, and MEA).

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: [email protected]